In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out

Emilie Skytte Andersen; Signe Foghsgaard; Louise Vedtofte; Julie Forman; Tine Dalsgaard  Clausen; Jens Anton Svare; Elisabeth Reinhardt Mathiesen; Peter Damm; Jens J.  Holst; Filip Krag Knop; Tina Vilsbøll

In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out

Emilie Skytte Andersen, Signe Foghsgaard, Louise Vedtofte, Julie Forman, Tine Dalsgaard Clausen, Jens Anton Svare, Elisabeth Reinhardt Mathiesen, Peter Damm, Jens J. Holst, Filip Krag Knop, Tina Vilsbøll

Original language	English
Journal	Diabetes
ISSN	0012-1797
Publication status	Published - Jun 2021
Event	American Diabetes Association's 81st Scientific Sessions, ADA - Duration: 25 Jun 2021 → 29 Jun 2021

Conference

Conference	American Diabetes Association's 81st Scientific Sessions, ADA
Period	25/06/2021 → 29/06/2021

Cite this

Andersen, E. S., Foghsgaard, S., Vedtofte, L., Forman, J., Clausen, T. D., Svare, J. A., Mathiesen, E. R., Damm, P., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2021). In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out. Diabetes.

In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out. / Andersen, Emilie Skytte; Foghsgaard, Signe; Vedtofte, Louise et al.
In: Diabetes, 06.2021.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Andersen, ES, Foghsgaard, S, Vedtofte, L, Forman, J, Clausen, TD, Svare, JA, Mathiesen, ER , Damm, P, Holst, JJ, Knop, FK & Vilsbøll, T 2021, 'In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out', Diabetes.

@article{8713bd2383134530b8368862046993a3,

title = "In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out",

author = "Andersen, \{Emilie Skytte\} and Signe Foghsgaard and Louise Vedtofte and Julie Forman and Clausen, \{Tine Dalsgaard\} and Svare, \{Jens Anton\} and Mathiesen, \{Elisabeth Reinhardt\} and Peter Damm and Holst, \{Jens J.\} and Knop, \{Filip Krag\} and Tina Vilsb{\o}ll",

year = "2021",

month = jun,

language = "English",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association",

note = "American Diabetes Association's 81st Scientific Sessions, ADA ; Conference date: 25-06-2021 Through 29-06-2021",

}

TY - ABST

T1 - In Women with Prior Gestational Diabetes Mellitus, the Glucagon-like Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-out

AU - Andersen, Emilie Skytte

AU - Foghsgaard, Signe

AU - Vedtofte, Louise

AU - Forman, Julie

AU - Clausen, Tine Dalsgaard

AU - Svare, Jens Anton

AU - Mathiesen, Elisabeth Reinhardt

AU - Damm, Peter

AU - Holst, Jens J.

AU - Knop, Filip Krag

AU - Vilsbøll, Tina

PY - 2021/6

Y1 - 2021/6

M3 - Conference abstract in journal

SN - 0012-1797

JO - Diabetes

JF - Diabetes

T2 - American Diabetes Association's 81st Scientific Sessions, ADA

Y2 - 25 June 2021 through 29 June 2021

ER -